Probiotics for Birch Pollen Allergy

计划入组 47 人 · 首次发布于 2008 年 9 月 3 日

Study of DM-101PX in Adults With Birch Pollen Allergy

计划入组 97 人 · 首次发布于 2025 年 11 月 28 日

Safety and Efficacy of Low-dose IL-2 in Birch Pollen Allergy

计划入组 24 人 · 首次发布于 2018 年 12 月 17 日

Birch pollen allergy vaccine(Anergis)

Birch pollen allergy vaccine(ALK-Abello)

Birch pollen allergy immunotherapy(LETI Pharma GmbH)

Allergy Laboratories, Inc.

United States

Halton Pediatric Allergy

Canada

HAL Allergy BV

Netherlands

NICE Approves First-in-Class Birch Pollen Immunotherapy for Severe Hayfever on NHS

Stallergenes Greer to Present Paediatric Phase III YOBI Data and Real-World EfficAPSI Findings at EAACI 2026

Regeneron's First-in-Class Allergen-Blocking Antibodies Show 52% Reduction in Cat Allergy Symptoms in Phase 3 Trials